close

Articles

Clinical profile, management and outcomes of patients taking dual pathway inhibition for cardiovascular protection in clinical practice in Latin America. Data from the XATOA registry

Juan Rene Cornejo-Avendaño, Carlos Novoa, Gerardo Peón, Carlos Rapallo, Alejandro Ricalde Alcocer, Nestor Alejandro Vita, Luis Ramón Virgen-Carrillo, Carlos Felipe Barrera-Ramírez, Eduardo Ramacciotti

Article Type

Original Research

Published

This study aims to determine the clinical profile, management and outcomes of patients with coronary artery disease, peripheral artery disease or both, initiating dual pathway inhibition using rivaroxaban 2.5 mg twice daily plus aspirin in clinical practice in Latin America.

Read more

Advances in the management of allergic rhinitis: clinical relevance of the mometasone furoate–olopatadine association and the challenge of patient self-diagnosis and self-treatment

Maria D’Amato, Gennaro D’Amato

Article Type

Review

Published

This narrative review examines advances in allergic rhinitis management with a focus on the fixed-dose mometasone furoate/olopatadine hydrochloride combination, contextualizing its pharmacological rationale, clinical evidence and potential role in addressing persistent treatment gaps and the growing issue of self-diagnosis and self-medication.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.